Navigation Links
Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
Date:10/25/2009

WASHINGTON, Oct. 25, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported that data from the pivotal BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) Phase 3 trial demonstrate lorcaserin significantly increased excess weight loss, improved markers of cardiovascular risk and glycemic parameters, and was not associated with depression or suicidal ideation. Additional subgroup analyses showed that lorcaserin caused the greatest improvements in lipid profiles, glycemic parameters and other markers of cardiovascular risk in patients in the highest risk categories. The new data were presented at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society.

"There is an enormous unmet need for new weight management treatments to help address the obesity epidemic. If approved, lorcaserin's unique combination of efficacy, safety and tolerability will make it suitable as first-line therapy for weight management," said Steven R. Smith, M.D., Executive Director of the Florida Hospital Translational Research Institute for Metabolism and Diabetes. "Based on the results from lorcaserin's pivotal program, physicians and patients can expect treatment with lorcaserin, along with a lifestyle modification program, to result in average weight loss of nearly 20 pounds and a significant reduction in their excess weight over one year, while improving important risk factors and quality of life. Lorcaserin was very well tolerated; the most common side effect was mild and transient headache early in treatment."

Specifically, the new data show that lorcaserin increased excess weight loss during Year 1 of the BLOOM trial. Lorcaserin patients who completed the trial according to protocol lost 31.0% of their excess weight compared to 12.0% for the placebo group. This measurement is
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
2. UCLA/RAND study shows that many children of HIV-positive parents are not in their custody
3. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
4. Nutrition model stresses positive experience of eating
5. Ultrasound plus mammography finds more cancers, but increases false positives
6. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
7. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
8. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
9. Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness
10. A low prevalence of H pylori in HIV-positive patients
11. Drug Company-Funded Asthma Drug Studies More Positive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... Lakeview Health, a nationally recognized ... Overdose Awareness Day. The goal is to provide people information regarding drugs and ... they may get help. , Lakeview Health will be publishing information ...
(Date:9/2/2015)... Hanover, MA (PRWEB) , ... September 02, 2015 ... ... to celebrate September as Brain Aneurysm Awareness Month , which was established ... J. Donato. , “Spreading awareness and education, and helping fund more research remains ...
(Date:9/2/2015)... Chicago, IL (PRWEB) , ... September 02, 2015 ... ... kicks off ahead of Breast Cancer Awareness Month (BCAM), Bright Pink, a national ... in young women, will launch Act On Facts, a campaign to educate women ...
(Date:9/1/2015)... ... September 01, 2015 , ... An August 25 article ... surgeries conducted each year on teenagers, quoting a New York City-area plastic surgeon ... plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more familiarly to patients and ...
(Date:9/1/2015)... ... 01, 2015 , ... The Capillus82™ has been cleared by ... in adults, announces Miami-based medical device manufacturer, Capillus, LLC. FDA clearance substantiates the ... when used at home to combat hair loss. , “Following the success ...
Breaking Medicine News(10 mins):Health News:August 31 is International Overdose Awareness Day – Lakeview Health to Help Bring Awareness 2Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2
... how to avoid injury while performing winter task , , ... your driveway and sidewalks can be physically challenging and ... and safety precautions, says the American Academy of Orthopaedic ... people were treated in U.S. hospital emergency rooms, doctors, ...
... say it,s the best way to keep colds and flu ... the advice your mother gave you, there,s one tidbit that doctors ... Wash your hands. , Keeping hands free of germs is one ... the flu, a cold or some other infectious disease, experts say. ...
... value of molecular imaging in nodal staging of patients ... time to accurately distinguish between cancerous cells in regional ... surgery. , Researchers from the University of Erlangen-Nrnberg, Germany, ... The Journal of Nuclear Medicine on the ...
... School Of Dentistry release results of clinical data that ... is among the first to acknowledge that even short-term ... jaw vulnerable to devastating necrosis, according to the report ... American Dental Association ( JADA ). , Osteoporosis ...
... For over a decade, Equinox Fitness Clubs has been known ... Fitness and Exercise Physiologist Carol Espel offers tips and advice ... routine in 2009. "The most successful results occur ... says Espel. "The challenging piece should come in ...
... blood cancers, researchers say , , WEDNESDAY, Dec. 31 (HealthDay ... exposed to an extract from grape seeds died within ... unharmed, a new study shows. , University of Kentucky ... a protein that regulates the cell-signaling pathway the leads ...
Cached Medicine News:Health News:Shovel Snow Safely 2Health News:To Protect Yourself, Wash Those Germs Away 2Health News:To Protect Yourself, Wash Those Germs Away 3Health News:To Protect Yourself, Wash Those Germs Away 4Health News:Molecular imaging enables earlier, individualized treatment of thyroid cancer 2Health News:USC dentist links Fosomax-type drugs to jaw necrosis 2Health News:Resolve for Results: 10 Tips From Equinox Fitness Club to Help You Keep Your Resolutions in '09 2Health News:Grape Seed Extract Kills Leukemia Cells in Lab 2
(Date:9/1/2015)... 1, 2015   Ivenix Inc. , a ... system, closed on a $42M round of equity ... Cardinal Partners, CICA, Inc., Easterly Capital, Fidelity Biosciences, ... round. This financing will support the company,s efforts ... Partners LLC acted as the exclusive placement agent ...
(Date:9/1/2015)... CytRx Corporation (NASDAQ: CYTR ), ... oncology, today announced that Steven A. Kriegsman ... David Haen , Vice President of Business Development ... at two significant investment conferences in September, 2015 ... FBR & Co. Second Annual Health Conference and ...
(Date:9/1/2015)... Research and Markets ( http://www.researchandmarkets.com/research/r8v22b/regulatory ) has ... Support Staff (London, UK - September 24-25, 2015)" ... day course provides an introduction to Pharmaceutical Regulatory Affairs ... designed specifically for those working in a support staff ... of EU regulatory procedures required to register products in ...
Breaking Medicine Technology:Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4Regulatory Affairs for Support Staff Seminar (London, UK - September 24-25, 2015) 2
... Innova™ 4100, the worlds first ... for angiographic imaging, incorporates GEs ... tiled Digital Detector (41cm X ... high resolution imaging across the ...
... The RX imola is a ... analyser that offers a host of ... systems. The RX imola has the ... tests per hour plus ISEs, and ...
Inquire...
... Human sex hormone-binding globulin (SHBG) is a ... with relatively high specificity and low capacity, ... to SHBG) and, to a much lesser ... and C19 steroid structures and regulates the ...
Medicine Products: